SAM
GBT

Shell Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Shell Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,214
Closed -$151K – 1426
2022
Q3 		$151K Sell
2,214
-555
-20% -$30.6K 0.01% 1104
2022
Q2 		$88K Buy
2,769
+10
+0.4% +$293 ﹤0.01% 1306
2022
Q1 		$96K Sell
2,759
-416
-13% -$12.4K ﹤0.01% 1301
2021
Q4 		$93K Sell
3,175
-52
-2% -$1.61K ﹤0.01% 1332
2021
Q3 		$82K Sell
3,227
-130
-4% -$3.82K ﹤0.01% 1323
2021
Q2 		$118K Hold
3,357
– – ﹤0.01% 1334
2021
Q1 		$137K Sell
3,357
-944
-22% -$43.4K ﹤0.01% 1229
2020
Q4 		$186K Hold
4,301
– – ﹤0.01% 1137
2020
Q3 		$237K Hold
4,301
– – 0.01% 994
2020
Q2 		$272K Sell
4,301
-85
-2% -$5.83K 0.01% 934
2020
Q1 		$224K Sell
4,386
-67
-2% -$4.49K 0.01% 975
2019
Q4 		$354K Sell
4,453
-132
-3% -$7.82K 0.01% 1004
2019
Q3 		$222K Sell
4,585
-39
-0.8% -$2.03K 0.01% 1110
2019
Q2 		$243K Sell
4,624
-106
-2% -$6.09K 0.01% 1091
2019
Q1 		$250K Buy
+4,730
New +$232K 0.01% 1072

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Shell Asset Management's GBT Position: Q4 2022 in Review

Shell Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2,214 shares — an estimated $151K sold.

Shell Asset Management first reported a position in GBT in Q1 2019 and held it in 15 quarters. The position peaked at $354K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Shell Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Shell Asset Management sold 2,214 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $151K.
  • Shell Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 15 quarters.
  • Shell Asset Management's Global Blood Therapeutics, Inc. position peaked at $354K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Shell Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.